Rhumbline Advisers Theravance Biopharma, Inc. Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 92,179 shares of TBPH stock, worth $781,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,179
Previous 96,790
4.76%
Holding current value
$781,677
Previous $1.09 Million
24.01%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding TBPH
# of Institutions
124Shares Held
49.6MCall Options Held
1.4KPut Options Held
2.3K-
Weiss Asset Management LP Boston, MA7.46MShares$63.2 Million2.91% of portfolio
-
Madison Avenue Partners, LP New York, NY7.01MShares$59.5 Million12.55% of portfolio
-
Seth Klarman Baupost Group LLC | Boston, Ma6.59MShares$55.9 Million1.62% of portfolio
-
Black Rock Inc. New York, NY4.21MShares$35.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$23.4 Million5.05% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $566M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...